ANDAOPHTHALMICSOLUTION/DROPS
Approved
Apr 2001
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
HCl, a cardioselective (beta-1-adrenergic) receptor inhibitor, does not have significant membrane-stabilizing (local anesthetic) activity and is devoid of intrinsic sympathomimetic action. Orally administered beta-adrenergic receptor inhibitors reduce cardiac output in healthy subjects and patients…